Treatment Discontinuation Patterns for Patients with Chronic Lymphocytic Leukemia in Real-World Settings: Results from a Multi-Center International Study

This study assessed treatment discontinuation patterns and reasons among chronic lymphocytic leukemia (CLL) patients initiating first-line (1L) and second line (2L) treatments in real-world settings.

Source: Clinical Lymphoma, Myeloma and Leukemia - March 23, 2023 Category: Hematology Authors: Mazyar Shadman, Beenish S. Manzoor, Kavita Sail, Hande H. Tuncer, John N. Allan, Chaitra Ujjani, Nnadozie Emechebe, Rajesh Kamalakar, Catherine C. Coombs, Lori Leslie, Paul M. Barr, Jennifer R. Brown, Toby A. Eyre, Alexandros Rampotas, Anna Schuh, Nicole Source Type: research